Position
SIMPLEX TRADING, LLC in Ovid Therapeutics Inc.
Back to the book · All holders of OVID
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.17K$1.63 → $2.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 31.6K | $51.5K | — | — | — | 0.0% |
| Q1 2026 | 3.67K | $8.16K | $2.22 | $2.17K | −$45.5K | 0.0% |